Scinovex
reviewTop 1% cited

Re-evaluation of risks associated with hyperphosphatemia and hyperparathyroidism in dialysis patients: Recommendations for a change in management

American Journal of Kidney Diseases · 2000 · Vol. 35(6) · pp. 1226–1237
Geoffrey A. BlockFriedrich K. Port
Parathyroid Disorders and TreatmentsDialysis and Renal Disease ManagementMuscle and Compartmental DisordersHyperphosphatemiaMedicineDialysisSecondary hyperparathyroidismRenal osteodystrophyParathyroid hormonePhosphorusInternal medicineHemodialysisHyperparathyroidism

MeSH terms

CalcinosisCalciumCardiovascular DiseasesEvaluation Studies as TopicHeart ArrestRenal DialysisHumansHyperparathyroidism, SecondaryKidney Failure, ChronicParathyroid HormonePhosphatesPhosphorusChronic Kidney Disease-Mineral and Bone DisorderRisk FactorsVascular Diseases
Citations
595
FWCI
30.72
field-weighted impact
References
89
Percentile
100%
vs. same field & year
Citations per year
Cited by
Phosphate Regulation of Vascular Smooth Muscle Cell Calcification
Circulation Research · 2000 · 1,407 citations
Bone metabolism and disease in chronic kidney disease
American Journal of Kidney Diseases · 2003 · 1,261 citations
Activated Injectable Vitamin D and Hemodialysis Survival
Journal of the American Society of Nephrology · 2005 · 784 citations
Citation Network

How this paper connects to the literature. Drag to explore, click any node to open that paper.

Re-evaluation of risks associated with hyperphosphatemia and hyperparathyroidism in dialysis patients: Recommendations for a change in management · Scinovex